INHIBITORS OF PDE4 BINDING TO HSP20

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130209439A1
SERIAL NO

13878404

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods and materials for use in increasing HSP20 activation in a biological system, for example by increasing phosphorylation of Ser16 of HSP20. In one aspect, the invention provides a method for increasing HSP20 activation in a biological system, comprising contacting the system with an antagonist capable of inhibiting PDE4 binding to HSP20, the antagonist comprising or consisting essentially of a fragment of PDE4 or an analogue thereof. In a further aspect the invention provides a method of screening for an agent able to increase activation of HSP20. A preferred antagonist has a C-terminal lysine residue.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOWGLASGOW STRATHCLYDE GB

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baillie, George S Glasgow, GB 3 0
Day, Jon Glasgow, GB 3 2
Houslay, Miles Glasgow, GB 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation